MM&M

J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity

Johnson & Johnson’s reported sales rose 5.2% during Q3, though its earnings declined significantly due to its ongoing M&A activity. The pharma giant released its latest earnings report Thursday ...
Seeking Alpha

J&J Snack Foods: Fairly Valued, Though It's Getting Harder To Say No To This Treat

For the final quarter of the 2025 fiscal year, J&J Snack Foods reported revenue of $410.2 million. Although this is a nice chunk of change, it did fall short of the $426.8 million in sales the company ...
Seeking Alpha

J&J Snack Foods: Slow Growth And High Valuation Raise Red Flags

J&J Snack Foods delivered Q3 2025 revenue growth of 3.2%, led by strong Food Service and Frozen Beverages segments. JJSF's Food Service segment grew 4.8%, driven by demand for soft pretzels and Dippin ...
MM&M

J&J’s Tremfya TV ad calls out psoriasis diagnosis gap for patients of color

Johnson & Johnson recently rolled out a TV ad that takes aim at a major disparity in dermatology: the fact that people of color with psoriasis are 70% less likely to be prescribed a biologic than ...